1. Home
  2. JAGX vs ZCMD Comparison

JAGX vs ZCMD Comparison

Compare JAGX & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.96

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Logo Zhongchao Inc.

ZCMD

Zhongchao Inc.

HOLD

Current Price

$1.40

Market Cap

2.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
ZCMD
Founded
2013
2012
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.0M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
JAGX
ZCMD
Price
$0.96
$1.40
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
66.1K
9.2M
Earning Date
04-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
N/A
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.02
52 Week High
$8.00
$11.96

Technical Indicators

Market Signals
Indicator
JAGX
ZCMD
Relative Strength Index (RSI) 22.36 48.13
Support Level $0.60 $0.75
Resistance Level $0.99 $3.11
Average True Range (ATR) 0.24 1.31
MACD -0.13 0.01
Stochastic Oscillator 0.00 0.75

Price Performance

Historical Comparison
JAGX
ZCMD

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provides healthcare information, education, and training services to healthcare professionals under its MDMOOC brand. It also provides focused patient management services through the Zhongxun IT system and WeChat mini program, and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

Share on Social Networks: